# Effect of Self-administered tDCS in Patients With MDD

> **NCT04543123** · PHASE4 · COMPLETED · sponsor: **Jeong-Ho Chae** · enrollment: 58 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** tDCS treatment
- **DRUG:** Antidepressant Drug(escitalopram)

## Key facts

- **NCT ID:** NCT04543123
- **Lead sponsor:** Jeong-Ho Chae
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-16
- **Primary completion:** 2019-05-02
- **Final completion:** 2019-05-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04543123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04543123, "Effect of Self-administered tDCS in Patients With MDD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04543123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*